Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pascal Vranckx

Showing results (131-140 of 305) with videos related to

Pageof 31
Sort By:
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|February 8, 2012
Does the site of bleeding matter? A stratified analysis on location of TIMI-graded bleedings and their impact on 12-month outcome in patients with ST-segment elevation myocardial infarctionPascal Vranckx, Gianluca Campo, Maurizio Anselmi, et al.
Archives of Internal Medicine|March 30, 2011
Contemporary mortality differences between primary percutaneous coronary intervention and thrombolysis in ST-segment elevation myocardial infarctionMarc J Claeys, Antoine de Meester, Carl Convens, et al.
European Heart Journal. Acute Cardiovascular Care|July 2, 2021
'Ticagrelor alone vs. dual antiplatelet therapy from 1 month after drug-eluting coronary stenting among patients with STEMI': a post hoc analysis of the randomized GLOBAL LEADERS trialAmr S Gamal, Hironori Hara, Mariusz Tomaniak, et al.
JACC. Cardiovascular Interventions|May 12, 2018
Defining Staged Procedures for Percutaneous Coronary Intervention Trials: A Guidance DocumentErnest Spitzer, Eugène McFadden, Pascal Vranckx, et al.
American Heart Journal|May 16, 2016
Risk and timing of recurrent ischemic events among patients with stable ischemic heart disease, non-ST-segment elevation acute coronary syndrome, and ST-segment elevation myocardial infarctionThomas Pilgrim, Pascal Vranckx, Marco Valgimigli, et al.
Circulation|June 17, 2009
Intensifying platelet inhibition with tirofiban in poor responders to aspirin, clopidogrel, or both agents undergoing elective coronary intervention: results from the double-blind, prospective, randomized Tailoring Treatment with Tirofiban in Patients Showing Resistance to Aspirin and/or Resistance to Clopidogrel studyMarco Valgimigli, Gianluca Campo, Nicoletta de Cesare, et al.
Revista Espanola De Cardiologia (English Ed.)|March 11, 2020
Choice of access site and type of anticoagulant in acute coronary syndromes with advanced Killip class or out-of-hospital cardiac arrestGiuseppe Gargiulo, Marco Valgimigli, Mikael Sunnåker, et al.
European Heart Journal. Acute Cardiovascular Care|March 26, 2024
European practices on antithrombotic management during percutaneous mechanical circulatory support in adults: a survey of the Association for Acute CardioVascular Care of the ESC and the European branch of the Extracorporeal Life Support OrganizationCharlotte J Van Edom, Justyna Swol, Thomas Castelein, et al.
European Heart Journal. Acute Cardiovascular Care|September 25, 2013
STEMI mortality in community hospitals versus PCI-capable hospitals: results from a nationwide STEMI network programmeMarc J Claeys, Peter R Sinnaeve, Carl Convens, et al.
Lancet (London, England)|September 8, 2019
Edoxaban-based versus vitamin K antagonist-based antithrombotic regimen after successful coronary stenting in patients with atrial fibrillation (ENTRUST-AF PCI): a randomised, open-label, phase 3b trialPascal Vranckx, Marco Valgimigli, Lars Eckardt, et al.
Pageof 31

Showing results (131-140 of 305) with videos related to

Sort By:
Pageof 31
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|February 8, 2012
Does the site of bleeding matter? A stratified analysis on location of TIMI-graded bleedings and their impact on 12-month outcome in patients with ST-segment elevation myocardial infarctionPascal Vranckx, Gianluca Campo, Maurizio Anselmi, et al.
Archives of Internal Medicine|March 30, 2011
Contemporary mortality differences between primary percutaneous coronary intervention and thrombolysis in ST-segment elevation myocardial infarctionMarc J Claeys, Antoine de Meester, Carl Convens, et al.
European Heart Journal. Acute Cardiovascular Care|July 2, 2021
'Ticagrelor alone vs. dual antiplatelet therapy from 1 month after drug-eluting coronary stenting among patients with STEMI': a post hoc analysis of the randomized GLOBAL LEADERS trialAmr S Gamal, Hironori Hara, Mariusz Tomaniak, et al.
JACC. Cardiovascular Interventions|May 12, 2018
Defining Staged Procedures for Percutaneous Coronary Intervention Trials: A Guidance DocumentErnest Spitzer, Eugène McFadden, Pascal Vranckx, et al.
American Heart Journal|May 16, 2016
Risk and timing of recurrent ischemic events among patients with stable ischemic heart disease, non-ST-segment elevation acute coronary syndrome, and ST-segment elevation myocardial infarctionThomas Pilgrim, Pascal Vranckx, Marco Valgimigli, et al.
Circulation|June 17, 2009
Intensifying platelet inhibition with tirofiban in poor responders to aspirin, clopidogrel, or both agents undergoing elective coronary intervention: results from the double-blind, prospective, randomized Tailoring Treatment with Tirofiban in Patients Showing Resistance to Aspirin and/or Resistance to Clopidogrel studyMarco Valgimigli, Gianluca Campo, Nicoletta de Cesare, et al.
Revista Espanola De Cardiologia (English Ed.)|March 11, 2020
Choice of access site and type of anticoagulant in acute coronary syndromes with advanced Killip class or out-of-hospital cardiac arrestGiuseppe Gargiulo, Marco Valgimigli, Mikael Sunnåker, et al.
European Heart Journal. Acute Cardiovascular Care|March 26, 2024
European practices on antithrombotic management during percutaneous mechanical circulatory support in adults: a survey of the Association for Acute CardioVascular Care of the ESC and the European branch of the Extracorporeal Life Support OrganizationCharlotte J Van Edom, Justyna Swol, Thomas Castelein, et al.
European Heart Journal. Acute Cardiovascular Care|September 25, 2013
STEMI mortality in community hospitals versus PCI-capable hospitals: results from a nationwide STEMI network programmeMarc J Claeys, Peter R Sinnaeve, Carl Convens, et al.
Lancet (London, England)|September 8, 2019
Edoxaban-based versus vitamin K antagonist-based antithrombotic regimen after successful coronary stenting in patients with atrial fibrillation (ENTRUST-AF PCI): a randomised, open-label, phase 3b trialPascal Vranckx, Marco Valgimigli, Lars Eckardt, et al.
Pageof 31